Japanese Encephalitis News and Research

RSS
Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.
Computer model can predict malaria epidemics in India

Computer model can predict malaria epidemics in India

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

Experimental sublingual vaccine shows promise against influenza infection

Experimental sublingual vaccine shows promise against influenza infection

Inviragen commences DENVax Phase 2 trial for dengue

Inviragen commences DENVax Phase 2 trial for dengue

New creative uses of DNA 'barcoding'

New creative uses of DNA 'barcoding'

IVI receives WHO prequalification for new oral cholera vaccine

IVI receives WHO prequalification for new oral cholera vaccine

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Bharat Biotech announces the pricing for ROTAVAC vaccine

Bharat Biotech announces the pricing for ROTAVAC vaccine

Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac reports fourth quarter net sales of $9.1 million

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

ITMNs can reduce Japanese Encephalitis transmission to humans

ITMNs can reduce Japanese Encephalitis transmission to humans

Sinovac submits clinical trial application for 13-valent pneumococcal conjugate vaccine to China SFDA

Sinovac submits clinical trial application for 13-valent pneumococcal conjugate vaccine to China SFDA

Intercell reports EUR 255.2m net loss for full year 2010

Intercell reports EUR 255.2m net loss for full year 2010

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Global Health Consortium to support development of vaccines to control dengue fever

Global Health Consortium to support development of vaccines to control dengue fever

Inviragen completes memorandum of understanding with Duke-NUS

Inviragen completes memorandum of understanding with Duke-NUS

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch